Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
ACS Pharmacology & Translational Science|April 8, 2020
Selective Allosteric Modulation of N-Terminally Cleaved, but Not Full Length CCL3 in CCR1Olav Larsen, Michael Lückmann, Wijnand J C van der Velden, et al.
European Journal of Medicinal Chemistry|June 11, 2018
Ligand-selective small molecule modulators of the constitutively active vGPCR US28Roxana-Maria Amărandi, Michael Lückmann, Motiejus Melynis, et al.
Chemical Biology & Drug Design|August 30, 2016
Structure-based discovery of novel US28 small molecule ligands with different modes of actionMichael Lückmann, Roxana-Maria Amarandi, Natalia Papargyri, et al.
Frontiers in Immunology|October 2, 2019
Biased Signaling of CCL21 and CCL19 Does Not Rely on N-Terminal Differences, but Markedly on the Chemokine Core Domains and Extracellular Loop 2 of CCR7Astrid S Jørgensen, Olav Larsen, Edith Uetz-von Allmen, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 11, 2018
Translating biased signaling in the ghrelin receptor system into differential in vivo functionsFranziska Mende, Cecilie Hundahl, Bianca Plouffe, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 16, 2019
Molecular dynamics-guided discovery of an ago-allosteric modulator for GPR40/FFAR1Michael Lückmann, Mette Trauelsen, Marie A Bentsen, et al.
Structure (London, England : 1993)|April 23, 2021
Investigating GIPR (ant)agonism: A structural analysis of GIP and its receptorFlorent X Smit, Wijnand J C van der Velden, Hüsün S Kizilkaya, et al.
Molecular Metabolism|February 17, 2015
GPR40 (FFAR1) - Combined Gs and Gq signaling in vitro is associated with robust incretin secretagogue action ex vivo and in vivoMaria Hauge, Marie A Vestmar, Anna S Husted, et al.
Bioorganic & Medicinal Chemistry Letters|January 21, 2015
Optimisation of in silico derived 2-aminobenzimidazole hits as unprecedented selective kappa opioid receptor agonistsPradip K Sasmal, C Vamsee Krishna, S Sudheerkumar Adabala, et al.
Pageof 2